Your search for comorbidities returned 10 results

Patients diagnosed with new atrial fibrillation after ischemic stroke were more likely to have preexisting cardiovascular comorbidities such as hypertension, heart failure, and coronary artery disease.

Stroke/systemic embolism rates were comparable between patients with atrial fibrillation with or without heart failure.

The annual risk of sudden cardiac death/ventricular arrhythmias was higher in patients with atrial fibrillation vs patients without atrial fibrillation.

Atrial fibrillation was associated with a higher risk of adjusted in-hospital mortality and bleeding complications after both PCI and CABG.

Women with atrial fibrillation and diabetes have higher rates for mortality and cardiovascular disease compared to men.

In the 30 days following ablation, women had higher risk of developing complications, including vascular, hematoma or hemorrhage, and tamponade.

Researchers analyzed the relationship between chronotropic incompetence and exercise capacity in patients with chronic heart failure.

Two studies presented at CHEST 2016 revealed that rivaroxaban lowered the risk of venous thromboembolism without increasing risk of major bleeding.

Rhythm control is not superior to rate control in patients with atrial fibrillation, and higher BMI appears to lower mortality risks.

No differences between monotherapy and multiple anthrombotic therapy in rates of stroke, MACE, or death.